Metraipolis › archive › dc_8daf3efce4cd

The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy… — Europe PMC PMID:41315206

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41315206
DOI: 10.1038/s41408-[numero omesso]-6
License (as archived): solo-consultazione
Archived: 2026-10-07T22:04:12.802Z
SHA-256 of the archived text: 76914695dbb05f23ac6185b3923176dd8c6db838d5a24978cd4e22da0e14cbde
Stable URL of this page: https://metraipolis.com/documento/dc_8daf3efce4cd

How to cite

The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy… — Europe PMC PMID:41315206 — Europe PMC (en), https://europepmc.org/article/MED/41315206 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8daf3efce4cd (Metraipolis archive dc_8daf3efce4cd, sha256 76914695dbb05f23ac6185b3923176dd8c6db838d5a24978cd4e22da0e14cbde)

BibTeX

@misc{dc8daf3efce4cd,
  title = {The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy… — Europe PMC PMID:41315206},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41315206},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8daf3efce4cd; sha256 76914695dbb05f23ac6185b3923176dd8c6db838d5a24978cd4e22da0e14cbde},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41315206. Agents can read the archived copy with the MCP tool read_document.